Table 6.

Effect of HP and LP dietary conditions without and with vitamin D₃ on fasting markers of cardiovascular risk, oxidative stress, and aging as well as the calcifying propensity of blood (T50)

Variable	Insulin (IU/L)	HOMA-IR	Glucose (mmol/L)	HbA1C (%)	hsCRP (mg/dl)	Fibrinogen (mmol/L)	D-Dimers (μg/ml)	Homocysteine (μmol/L)	Albumin (g/L)	Triglycerides (mmol/L)	Total Cholesterol (mmol/L)	oxLDL (ng/ml)	Antiox. Capacity (μmol/L)	Lipid Peroxides (μmol/L)	Superoxide Dismutase (ng/ml)	8-oxo-2deoxy guanosine (urine) (μg/L)	T50a (Min)
HP baseline	9.2±1.4	1.71±0.17	3.99±0.33	5.2±0.2	1.38±0.11	2.9±0.2	0.22±0.06	11.0±1.4	46.0±1.1	0.99±0.09	4.44±0.20	385±27	253±22	385±38	4.26±0.31	3.39±0.21	340±32
LP baseline	9.4±1.2	1.74±0.15	4.02±0.31	5.2±0.2	1.42±0.12	2.9±0.2	0.24±0.07	10.8±1.5	45.9±1.2	1.00±0.07	4.45±0.23	419±30	256±25	398±33	4.27±0.27	3.39±0.22	300±34
HP W6	8.2±0.9	1.44±0.14	3.87±0.38	5.1±0.3	2.10±0.16	2.9±0.1	0.20±0.05	12.2±1.3	46.9±1.0	0.95±0.06	4.51±0.20	362±28	236±22	521b±42	4.84±0.30	5.55b±0.41	305±40
LP W6	9.1±1.1	1.64±0.14	3.92±0.35	5.2±0.3	1.58±0.11	2.9±0.2	0.26±0.06	10.9±1.2	46.8±0.9	0.93±0.07	4.50±0.22	397±32	234±24	478b±44	4.72±0.26	5.98b±0.42	274±29
HP plus D3 W11	9.4±1.2	1.92±0.24	4.16±0.25	5.1±0.2	1.39±0.12	2.8±0.1	0.28±0.05	12.0±1.3	46.0±0.9	0.97±0.06	4.50±0.24	435±33	240±21	449b±47	3.83±0.36	5.42b±0.44	308±39
LP plus D3 W11	9.3±1.0	1.82±0.18	4.04±0.29	5.1±0.2	1.79±0.14	2.8±0.1	0.30±0.06	12.3±1.2	46.3±1.0	0.95±0.05	4.6±0.23	439±37	241±19	448b±45	4.43±0.41	6.00b±0.47	259±27

Values are mean±SEM. HOMA-IR, homeostatis model assessment insulin resistance; HbA_1C, glycosylated hemoglobin; hsCRP, high-sensitivity C-reactive protein; oxLDL, oxidized low density lipoprotein; Antiox., antioxidant; W, week.

^an=7 in both groups.

^bP<0.05 for the intragroup comparison with baseline.